Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)
Abstract
Background Due to the non-specific clinical presentation of patients with pulmonary hypertension (PH), diagnosis is often delayed, consequently resulting in limited therapeutic success and an impaired prognosis. In this trial, we analysed the plasma concentrations of novel cardiovascular biomarkers that reflect different pathobiological pathways (sST2: soluble suppression of tumorigenicity 2, H-FABP: heart type fatty acid binding protein, suPAR:...
Paper Details
Title
Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)
Published Date
Mar 1, 2020
Journal
Volume
29
Issue
3
Pages
337 - 344
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History